Komori
MANAC Chemical Partners (4360) · RiskMitigated

Delays or failures in developing new products and technologies

First written in FY2022. 5 of 6 entries say "Mitigated", first in FY2024. Latest entry: FY2026.

6entries
5years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022MitigatedFY2024 – FY20262022: 120222023: 020232024: 120242025: 120252026: 32026
Same theme, other companies
New Product Development Failures, Delays and WithdrawalsA theme 38 companies write about · 38 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2026: 5 of 15 companies on the "Worse" side.

4 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 38 companies compared. The sentences above are computed from all 38.
Full recordFilings, disclosures and news, newest first
  1. FY2026MitigatedAnnual report

    「To respond quickly to these market changes, the Group supports customers in launching mass production from both technical and production perspectives and is working to shorten development periods and ensure commercialization.」

    As a measure addressing the risk of delays in developing new products and technologies, it has established a specific response involving support for customers' mass-production launches from both technical and production perspectives.
  3. FY2026-H1MitigatedAnnual report

    「Development of new products, including electronic materials and pharmaceutical-related products, is progressing smoothly,」

    Regarding the development of new products and technologies, it states that the development of new products is progressing smoothly, indicating the status of measures addressing the risk of development delays and failures.
  4. FY2024MitigatedAnnual report

    「At the Shonan Innovation Research Institute, the Group is engaged in research and development of new products and technologies and the development of new businesses.」

    As a response to the risk of delays or failures in developing new products and technologies, it is advancing research and development and developing new businesses at the Shonan Innovation Research Institute.
  5. FY2022First statedAnnual report

    「If the Group is unable to develop new products and technologies due to delays in responding to market changes, delays in development progress or other factors, its future growth and profitability may decline, affecting its performance and financial condition.」

    While the Group relies on strengthening existing businesses and developing new products, technologies and businesses, it identifies development delays and other factors as risks.
Moved together

"Investment in the renewal, expansion and rationalisation of production facilities" moved the same way as this thread, in the same document, in 5 of its 6 moves.

544443★123456
  1. ★This thread
  2. 1Investment in the renewal, expansion and rationalisation of production facilities5×
  3. 2Recovery in demand for fine chemicals and flame retardant products4×
  4. 3Consolidated results for the third quarter of the fiscal year ending March 20224×
  5. 4Addressing Cost Increases through Production Efficiency and Passing Costs through to Product Prices4×
  6. 5Payment of Dividends4×
  7. 6Ongoing Research and Development Activities3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
MANAC Chemical Partners's next results are scheduled for 2026-11-13. Read the earnings preview It last moved in the General Meetings of Shareholders of 2026-06-08: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.